Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication
Open accessThe DOI matches its Crossref record; 62 of the 67 references it cites were found in a registry or an index.
Abstract
Deregulation of cyclin D1 occurs in numerous human cancers through mutations, alternative splicing, and gene amplification. Although cancer-derived cyclin D1 mutants are potent oncogenes in vitro and in vivo, the mechanisms whereby they contribute to neoplasia are poorly understood. We now provide evidence derived from both mouse models and human cancer-derived cells revealing that nuclear accumulation of catalytically active mutant cyclin D1/CDK4 complexes triggers DNA rereplication, resulting from Cdt1 stabilization, which in turn triggers the DNA damage checkpoint and p53-dependent apoptosis. Loss of p53 through mutations or targeted deletion results in increased genomic instability and neoplastic growth. Collectively, the data presented reveal mechanistic insights into how uncoupling of critical cell cycle regulatory events will perturb DNA replication fidelity, thereby contributing to neoplastic transformation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, certain cyclin D mutants or C-terminally truncated variants encoded by an alternatively spliced mRNA (D1b) that lacks the Thr-286 codon are retained in the nucleus during S phase and are proposed to confer a neo-oncogenic function that triggers DNA re-replication, aneuploidy, and tumorigenesis (59-61).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139
Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., & Bonner, W. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5858 · Cited by 5,438 · cited 2×
“previously by Rogakou et al. (1998). Soluble and chromatin frac-”
MethodSherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · cited 2×
“…al. 1994; Herman et al. 1995; Barnes and Gillett 1998; Hibberts et al. 1999; Hosokawa et al. 1999; BaniHani et al. 2000; Hemmer et al. 2001; Ikeguchi et al. 2001; Jin et al. 2001); overexpression can result from gene amplification, chromosomal translocation, or protein stabilization (Sherr 1996).”
BackgroundCell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836 · cited 3×
“The deleterious effects of D1T286A-dependent DNA rereplication and genomic instability is initially opposed by p53-dependent apoptosis that occurs in response to DNA breaks, perturbations in DNA replication, and oncogene activation (Kastan and Bartek 2004).”
BackgroundDNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688 · cited 3×
“…remains controversial, activation of the DNA damage checkpoint signaling pathway in preneoplastic tissue is consistent with the former (Bartkova et al. 2005; Gorgoulis et al. 2005) and suggests that initial “hits” trigger DNA damage and p53-dependent apoptosis to counter accumulation…”
BackgroundGlycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 1×
“Ras also contributes to the accumulation of the cyclin D1 protein, via a pathway involving PI3K and Akt, which attenuates the GSK3 kinase (Franke et al. 1995, 1997); GSK3 -dependent phosphorylation of cyclin D1 on Thr286 promotes cyclin D1 proteolysis (Diehl et al. 1998).”
BackgroundSelf-citationDNA Replication in Eukaryotic Cells
Bell, S. P., & Dutta, A. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135425 · Cited by 2,060 · cited 2×
“During G1 phase, DNA replication origins are established via loading of ORC (origin recognition complex) followed by Cdt1/CDC6-dependent loading of the replicative MCM helicase (Bell and Dutta 2002).”
BackgroundActivation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009 · cited 3×
“Recent work revealed induction of DNA damage in premalignant tissue (Bartkova et al. 2005; Gorgoulis et al. 2005), suggesting a mechanism whereby oncogenic stress in nonmalignant cells may provide selective pressure to delete p53 and promote tumorigenesis.”
BackgroundFranke, T. F., Yang, S.-I., Chan, T. O., Datta, K., Kazlauskas, A., Morrison, D. K., Kaplan, D. R., & Tsichlis, P. N. (1995) · Cell · doi:10.1016/0092-8674(95)90534-0 · Cited by 2,006 · cited 1×
“Ras also contributes to the accumulation of the cyclin D1 protein, via a pathway involving PI3K and Akt, which attenuates the GSK3 kinase (Franke et al. 1995, 1997); GSK3 -dependent phosphorylation of cyclin D1 on Thr286 promotes cyclin D1 proteolysis (Diehl et al. 1998).”
BackgroundOncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · cited 1×
“Recent work has correlated oncogene-induced senescence with induction of the DNA damage checkpoint in solid tumors (Bartkova et al. 2006; Di Micco et al. 2006).”
BackgroundOncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821 · cited 1×
“Recent work has correlated oncogene-induced senescence with induction of the DNA damage checkpoint in solid tumors (Bartkova et al. 2006; Di Micco et al. 2006).”
Background
Cited by
Cyclin D as a therapeutic target in cancer
Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., & Sutherland, R. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3090 · Cited by 1,370
“, perhaps acting as a 'safety net' for rapidly proliferating cells, but sustained cyclin D1–CDK4 activity following DNA damage leads to the inappropriate re-replication of DNA and chromosomal damag”
BackgroundGaillard, H., García-Muse, T., & Aguilera, A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3916 · Cited by 1,089
Targeting CDK4 and CDK6: From Discovery to Therapy
Sherr, C. J., Beach, D., & Shapiro, G. I. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0894 · Cited by 936
Cyclin D1, cancer progression, and opportunities in cancer treatment
Qie, S., & Diehl, J. A. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1475-3 · Cited by 657
“Investigation of the mechanisms that underscore nuclear cyclin D1-dependent neoplastic growth revealed overexpression of the constitutively nuclear and stable cyclin D1 (T286A), but not wild-type cyclin D1, which promotes stabilization and mis-expression of the DNA replication licensing factor Cdt1, which then trigger…”
BackgroundSelf-citationNon-canonical functions of cell cycle cyclins and cyclin-dependent kinases
Hydbring, P., Malumbres, M., & Sicinski, P. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.27 · Cited by 528
Metadata
- Authors
- Aggarwal, P., Lessie, M. D., Lin, D. I., Pontano, L., Gladden, A. B., Nuskey, B., Goradia, A., Wasik, M. A., Klein-Szanto, A. J. P., Rustgi, A. K., Bassing, C. H., & Diehl, J. A.
- Affiliations
- University of Pennsylvania (US)
- Children's Hospital of Philadelphia (US)
- ORCID
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2007-11-15
- Volume
- 21
- Issue
- 22
- Pages
- 2908-2922
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC2049193
- OpenAlex
- W2112318168
- Cited by
- 132
- References
- 67
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 1 · 2022: 6 · 2021: 4 · 2020: 8 · 2019: 6 · 2018: 4 · 2017: 8 · 2016: 8 · 2015: 12 · 2014: 10 · 2013: 11 · 2012: 9
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA098101)
- National Cancer Institute (P01CA098101, R01CA093237, CA 93237)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- cyclin D1, Cdt1, CUL4, DNA re-replication, p53, DNA damage checkpoint, apoptosis, genomic instability, oncogenic transformation, S phase, DNA replication fidelity
- MeSH terms
- Animals, Cell Nucleus, Cells, Cultured, DNA, DNA Replication, DNA-Binding Proteins, DNA, Neoplasm, HeLa Cells, Humans, Hydrolysis, Lipopolysaccharides, Mice, Transgenic, Mutation, Osteosarcoma, Spleen, Tumor Suppressor Protein p53, S Phase, Cell Cycle Proteins, Cyclin D1, NIH 3T3 Cells, Cullin Proteins, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication. https://app.cochat.ai/papers/10.1101/gad.1586007
- The paper
- Aggarwal, P., Lessie, M. D., Lin, D. I., Pontano, L., Gladden, A. B., Nuskey, B., Goradia, A., Wasik, M. A., Klein-Szanto, A. J. P., Rustgi, A. K., Bassing, C. H., & Diehl, J. A. (2007). Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication. Genes & Development. https://doi.org/10.1101/gad.1586007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.